Key result
Phosphatidylcholine therapy is explored for enhancing reverse cholesterol transport, with trial data still needed.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Pownall et al. (2005) conducted a review in Atherosclerosis. Phosphatidylcholine therapy was evaluated on Reverse cholesterol transport. Phosphatidylcholine therapy is discussed for enhancing reverse cholesterol transport, though no quantitative trial results are reported in the provided text.
Synapse has enriched 10 related papers. Consider them for comparative context: